#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholangiocarcinoma Diffuse large B-cell lymphoma Juvenile psoriatic arthritis Chronic myelomonocytic leukaemia Oesophageal carcinoma Thalassaemia Interstitial lung disease Brain abscess Inborn error of metabolism Craniocerebral injury Carcinoid tumour IPEX syndrome Thalassaemia alpha Polycythaemia vera Uveal melanoma More trials…

    Learn about Rare Diseases

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Breast angiosarcoma – Diagnostics Haemophilia B with anti factor IX – Treatment Bronchiolitis obliterans syndrome Chondrosarcoma – Trials in Disease Progressive multifocal leukoencephalopathy – Diagnostics IgA nephropathy Piriformis syndrome – Life with Disease Primary mediastinal large B-cell lymphoma – Basic Information Cytokine release syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vonicog Alfa Fadraciclib Ganciclovir Sodium Diphenhydramine Hydrochloride Milvexian H2-Receptor Antagonist Forimtamig Datopotamab Deruxtecan Dexrazoxane Hydrochloride Clomipramine Hydrochloride Cctx-001 Inavolisib Pentosan Polysulfate Sodium Ethanol, Anhydrous Zidovudine Glucose Amlitelimab [18F]Alf-Nota-Octreotide Acp-017 ROC-101 HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Mixed dementia Neurofibrosarcoma Laparoscopic surgery Coronary artery bypass Barrett's oesophagus Pre-eclampsia Traumatic pain Peptostreptococcus infection Coronary artery disease Brain stem glioma Aortic disorder Lennox-Gastaut syndrome Chordoma Pyrexia Propionic acidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. KBC Zagreb

KBC Zagreb

Ulica Mije Kispatica 12, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bi 1015550
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    Austria Belgium Croatia Czechia Denmark Estonia +14

  • Study on AVP-786 for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Deudextromethorphan Hydrobromide
    • Quinidine Sulfate
    Belgium Croatia Hungary Ireland The Netherlands Slovakia +2

  • Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    • B-cell lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Belgium Bulgaria Croatia Czechia Denmark France +11

  • Study on Home Administration of Pertuzumab and Trastuzumab for Patients with Early or Locally Advanced HER2-Positive Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab
    • Trastuzumab Emtansine
    Bulgaria Croatia Spain

  • Study on the Safety and Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis and Myeloproliferative Neoplasms

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Navitoclax
    • Celecoxib
    • Ruxolitinib
    Bulgaria Croatia France Germany Italy Spain

  • Study on Lowering Cholesterol with Rosuvastatin or Rosuvastatin/Ezetimibe in Patients at High or Very High Risk of Cardiovascular Disease with High Cholesterol

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ezetimibe
    • Rosuvastatin
    Croatia Germany Hungary Poland Slovenia

  • Study on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Bezafibrate
    • Obeticholic Acid
    Belgium Croatia Czechia Estonia France Germany +6

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Risankizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Iclepertin
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Charcoal, Activated
    • Colestyramine
    • Magnesium Citrate
    Austria Belgium Bulgaria Croatia Denmark Ireland +7
Previous Page
1 … 11 12 13 14 15 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!